Skip to main content
. 2024 Sep 5;22:80. doi: 10.1186/s12959-024-00649-w

Table 2.

Summary of laboratory test results in the 36 patient samples. Variables with medians outside the reference intervals are marked in bold text

Median Range Interquartile range NAs Reference range
Coagulation tests
D-dimer (mg/L) 1.4 0.2–23.9 0.8–3.4 < 0.5
VWF: Act (IU/dL) 279 71–816 197–327 1 50–190
VWF: Ag (IU/dL) 377 118–1202 283–461 1 50–190
VWF: CB (%) 224 7-579 164–289 4 55–180
Fibrinogen (g/L) 5.9 1.8–9.2 5-7.3 2.0–4.0
FVIII activity (IU/mL) 216 91–461 168–280 60–160
Anti-Xa (IU/mL) 0.15 0-0.52 0.04–0.27 1 < 0.1
ADAMTS13 (%) 71 9-123 58–90 1 60–130
PT (%) 94 60–171 86–101 70–130
APTT (s) 32 17–106 29–35 28–37
Thrombin time (s) 20 17–28 18–21 4 17–25
Antithrombin (IU/dL) 89 20–121 79–102 85–125
Hematology
Hemoglobin (g/L) 114 79–148 100–129 *
Leukocytes (x109/L) 7.0 2.3–31.5 5.3–10.6 3.4–8.2
Platelet count (x109/L) 330 42–585 232–415 150–360
Chemistry
CRP (mg/L) 61 3-266 30–110 < 4
Creatinine (µmol/L) 48 28–279 41–67 **

* Hemoglobin ref interval 134–167 g/L for men, 117–155 g/L for women. ** Creatinine ref interval 50–90 µmol/L for women, 60–100 µmol/L for men

APTT, activated partial thromboplastin time; CRP, C reactive protein; PT, prothrombin time; VWF: Act, von Willebrand factor GPIb activity; VWF: Ag, VWF antigen VWF: CB, von Willebrand factor, collagen binding assay; NAs, samples with no results